Voyager Therapeutics, Inc. (VYGR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.51+3.85%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · VYGR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 34.5 | 40.4 | 80.0 | 250.0 | 40.9 | 37.4 | 171.1 | 104.4 | 7.6 | 10.1 | 14.2 | 17.3 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 10.1 | 14.2 | 17.3 |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 118.5 | 134.7 | 127.4 | 92.2 | 60.8 | 73.8 | 108.8 | 119.7 | 64.9 | 62.3 | 42.2 | 27.7 |
| Operating Income | (117.2) | (131.8) | (83.3) | 122.0 | (50.8) | (73.6) | 27.4 | (51.7) | (91.1) | (71.9) | (41.3) | (20.3) |
| Earnings from Continuing Operations | ||||||||||||
| Other Non-Operating Income / Expenses | 9.6 | 12.3 | 19.0 | 11.7 | 4.4 | 2.4 | 9.4 | 8.1 | 2.6 | 1.2 | 1.2 | — |
| EBT, Incl. Unusual Items | (107.6) | (119.6) | (64.3) | 133.7 | (46.4) | (71.2) | 36.7 | (43.6) | (88.5) | (70.7) | (40.1) | — |
| Income Tax Expense | 0.1 | 0.1 | 0.7 | 1.4 | 0.0 | — | — | (0.2) | (0.2) | 0.1 | 0.1 | — |
| Net Income | ||||||||||||
| Net Income | (107.7) | (119.7) | (65.0) | 132.3 | (46.4) | (71.2) | 36.7 | (43.6) | (88.3) | (70.7) | (40.2) | (29.7) |
| Per Share | ||||||||||||
| Basic EPS | (1.78) | (2.04) | (1.13) | 3.08 | (1.21) | (1.89) | 0.99 | — | — | — | — | — |
| Diluted EPS | (1.78) | (2.04) | (1.13) | 2.97 | (1.21) | (1.89) | 0.98 | — | — | — | — | — |
| Revenue per Share | 0.57 | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 |
| Basic Weighted Avg Shares | 60.5 | 58.7 | 57.7 | 43.0 | 38.4 | 37.7 | 37.1 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 60.5 | 58.7 | 57.7 | 44.6 | 38.4 | 37.7 | 37.3 | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBIT | (117.2) | (131.8) | (83.3) | 122.0 | (50.8) | (73.6) | 27.4 | (51.7) | (91.1) | (71.9) | (41.3) | (20.3) |
| Effective Tax Rate | -0.1% | — | — | 1.1% | -0.0% | — | — | 0.4% | 0.2% | -0.1% | -0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.